Clinigen Group

PROLEUKIN

Manufacturer:

Clinigen Group

Proleukin HCPCS:

J9015

HCPCS Code Descriptor:

Injection, aldesleukin, per single use vial

Category:

J Code

Proleukin NDCs:

76310-0022-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

76310-0022-01

About Proleukin:

PROLEUKIN is an Oncology drug manufactured by Clinigen Group and administered via the Intravenous route of administration. The J Code: J9015 is aligned to the drug PROLEUKIN.

ACCESS PRICING AND MORE BY REGISTERING

J9015 Added Date:

January 1, 1996

J9015 Effective Date:

January 1, 2009

J9015 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Proleukin billing and coding information.
Proleukin patient assistance information can be found through Proleukin Patient Support at the URL: https://proleukin.com/hcp/resources/
PROLEUKIN prescribing information can be found at the link below:
Information regarding PROLEUKIN’s side effects can be found at MedlinePlus